William Checkley1, Maria P Deza2, Jost Klawitter3, Karina M Romero4, Jelena Klawitter3, Suzanne L Pollard2, Robert A Wise2, Uwe Christians3, Nadia N Hansel2. 1. Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, USA. Electronic address: wcheckl1@jhmi.edu. 2. Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, USA. 3. iC42 Clinical Research and Development, University of Colorado, Aurora, CO, USA. 4. Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, USA; Biomedical Research Unit, A.B. PRISMA, Lima, Peru.
Abstract
BACKGROUND: The diagnosis of asthma in children is challenging and relies on a combination of clinical factors and biomarkers including methacholine challenge, lung function, bronchodilator responsiveness, and presence of airway inflammation. No single test is diagnostic. We sought to identify a pattern of inflammatory biomarkers that was unique to asthma using a targeted metabolomics approach combined with data science methods. METHODS: We conducted a nested case-control study of 100 children living in a peri-urban community in Lima, Peru. We defined cases as children with current asthma, and controls as children with no prior history of asthma and normal lung function. We further categorized enrollment following a factorial design to enroll equal numbers of children as either overweight or not. We obtained a fasting venous blood sample to characterize a comprehensive panel of targeted markers using a metabolomics approach based on high performance liquid chromatography-mass spectrometry. RESULTS: A statistical comparison of targeted metabolites between children with asthma (n = 50) and healthy controls (n = 49) revealed distinct patterns in relative concentrations of several metabolites: children with asthma had approximately 40-50% lower relative concentrations of ascorbic acid, 2-isopropylmalic acid, shikimate-3-phosphate, and 6-phospho-d-gluconate when compared to children without asthma, and 70% lower relative concentrations of reduced glutathione (all p < 0.001 after Bonferroni correction). Moreover, a combination of 2-isopropylmalic acid and betaine strongly discriminated between children with asthma (2-isopropylmalic acid ≤ 13 077 normalized counts/second) and controls (2-isopropylmalic acid > 13 077 normalized counts/second and betaine ≤ 16 47 121 normalized counts/second). CONCLUSIONS: By using a metabolomics approach applied to serum, we were able to discriminate between children with and without asthma by revealing different metabolic patterns. These results suggest that serum metabolomics may represent a diagnostic tool for asthma and may be helpful for distinguishing asthma phenotypes. Copyright Â
BACKGROUND: The diagnosis of asthma in children is challenging and relies on a combination of clinical factors and biomarkers including methacholine challenge, lung function, bronchodilator responsiveness, and presence of airway inflammation. No single test is diagnostic. We sought to identify a pattern of inflammatory biomarkers that was unique to asthma using a targeted metabolomics approach combined with data science methods. METHODS: We conducted a nested case-control study of 100 children living in a peri-urban community in Lima, Peru. We defined cases as children with current asthma, and controls as children with no prior history of asthma and normal lung function. We further categorized enrollment following a factorial design to enroll equal numbers of children as either overweight or not. We obtained a fasting venous blood sample to characterize a comprehensive panel of targeted markers using a metabolomics approach based on high performance liquid chromatography-mass spectrometry. RESULTS: A statistical comparison of targeted metabolites between children with asthma (n = 50) and healthy controls (n = 49) revealed distinct patterns in relative concentrations of several metabolites: children with asthma had approximately 40-50% lower relative concentrations of ascorbic acid, 2-isopropylmalic acid, shikimate-3-phosphate, and 6-phospho-d-gluconate when compared to children without asthma, and 70% lower relative concentrations of reduced glutathione (all p < 0.001 after Bonferroni correction). Moreover, a combination of 2-isopropylmalic acid and betaine strongly discriminated between children with asthma (2-isopropylmalic acid ≤ 13 077 normalized counts/second) and controls (2-isopropylmalic acid > 13 077 normalized counts/second and betaine ≤ 16 47 121 normalized counts/second). CONCLUSIONS: By using a metabolomics approach applied to serum, we were able to discriminate between children with and without asthma by revealing different metabolic patterns. These results suggest that serum metabolomics may represent a diagnostic tool for asthma and may be helpful for distinguishing asthma phenotypes. Copyright Â
Authors: Kian Fan Chung; Sally E Wenzel; Jan L Brozek; Andrew Bush; Mario Castro; Peter J Sterk; Ian M Adcock; Eric D Bateman; Elisabeth H Bel; Eugene R Bleecker; Louis-Philippe Boulet; Christopher Brightling; Pascal Chanez; Sven-Erik Dahlen; Ratko Djukanovic; Urs Frey; Mina Gaga; Peter Gibson; Qutayba Hamid; Nizar N Jajour; Thais Mauad; Ronald L Sorkness; W Gerald Teague Journal: Eur Respir J Date: 2013-12-12 Impact factor: 16.671
Authors: Michael J McGeachie; Amber Dahlin; Weiliang Qiu; Damien C Croteau-Chonka; Jessica Savage; Ann Chen Wu; Emily S Wan; Joanne E Sordillo; Amal Al-Garawi; Fernando D Martinez; Robert C Strunk; Robert F Lemanske; Andrew H Liu; Benjamin A Raby; Scott Weiss; Clary B Clish; Jessica A Lasky-Su Journal: Immun Inflamm Dis Date: 2015-05-07
Authors: Priyadarshini Kachroo; Isobel D Stewart; Rachel S Kelly; Meryl Stav; Kevin Mendez; Amber Dahlin; Djøra I Soeteman; Su H Chu; Mengna Huang; Margaret Cote; Hanna M Knihtilä; Kathleen Lee-Sarwar; Michael McGeachie; Alberta Wang; Ann Chen Wu; Yamini Virkud; Pei Zhang; Nicholas J Wareham; Elizabeth W Karlson; Craig E Wheelock; Clary Clish; Scott T Weiss; Claudia Langenberg; Jessica A Lasky-Su Journal: Nat Med Date: 2022-03-21 Impact factor: 87.241
Authors: Jesse D Hinckley; Laura Saba; Kristen Raymond; Karsten Bartels; Jost Klawitter; Uwe Christians; Christian Hopfer Journal: Cannabis Cannabinoid Res Date: 2020-06-19
Authors: Amanda P Pedroso; Ana P S Dornellas; Adriana P de Souza; Josias F Pagotto; Lila M Oyama; Cláudia M O Nascimento; Jelena Klawitter; Uwe Christians; Alexandre K Tashima; Eliane Beraldi Ribeiro Journal: Eur J Nutr Date: 2018-11-07 Impact factor: 5.614